The effect of Four Approaches to treat Actinic Keratosis on the HRQoL
<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a research archivist expert in dataset metadata. Answer the question truthfully.  <|eot_id|><|start_header_id|>user<|end_header_id|> Here is the Description of a dataset. Description:'To evaluate the impact of actinic keratosis (AK) and the effect of four AK treatments on the health-related quality of life (HRQoL), the Skindex-29 and AKQoL questionnaires were completed by 624 patients with AK participating in a randomized controlled trial (RCT) comparing 5% fluorouracil-cream, 5% imiquimod-cream, methyl-aminolevulinate photodynamic therapy (MAL-PDT), and 0.015% ingenol mebutate gel. Patients completed the questionnaires at baseline and 12 months post-treatment' . Please return only a json list of at most 3 Keywords corresponding to the Description:.<|eot_id|><|start_header_id|>assistant<|end_header_id|> {"Answer" : ["5% 5-fluorouracil","5% Imiquimod","actinic keratosis","Homo sapiens","photodynamic therapy","skin","Topical Ingenol mebutate"]} <|eot_id|>
 Here is the Description of a dataset. Description:'To evaluate the impact of actinic keratosis (AK) and the effect of four AK treatments on the health-related quality of life (HRQoL), the Skindex-29 and AKQoL questionnaires were completed by 624 patients with AK participating in a randomized controlled trial (RCT) comparing 5% fluorouracil-cream, 5% imiquimod-cream, methyl-aminolevulinate photodynamic therapy (MAL-PDT), and 0.015% ingenol mebutate gel. Patients completed the questionnaires at baseline and 12 months post-treatment' . Please return only a json list of at most 3 Keywords corresponding to the Description:.
To evaluate the impact of actinic keratosis (AK) and the effect of four AK treatments on the health-related quality of life (HRQoL), the Skindex-29 and AKQoL questionnaires were completed by 624 patients with AK participating in a randomized controlled trial (RCT) comparing 5% fluorouracil-cream, 5% imiquimod-cream, methyl-aminolevulinate photodynamic therapy (MAL-PDT), and 0.015% ingenol mebutate gel. Patients completed the questionnaires at baseline and 12 months post-treatment
5% 5-fluorouracil; 5% Imiquimod; actinic keratosis; Homo sapiens; photodynamic therapy; skin; Topical Ingenol mebutate